Publication date: Aug 01, 2024
We identified U. S. reports of postmenopausal bleeding in the VAERS (Vaccine Adverse Event Reporting System) between December 13, 2020, and December 13, 2021. Among 711,224 VAERS reports after coronavirus disease 2019 (COVID-19) vaccination, during our study period, we identified 554 presumptive postmenopausal bleeding reports; 434 were further classified as verified based on data abstracted from reports and medical records, when available. In the United States, by December 14, 2021, 58. 8 million women aged 50 years or older had received at least one dose of a COVID-19 vaccine, corresponding to approximately seven verified VAERS postmenopausal bleeding reports per 1 million women aged 50 years or older who received a COVID-19 vaccine. Reports of postmenopausal bleeding after COVID-19 vaccination in VAERS were rare, and causes of postmenopausal bleeding based on medical record review were consistent with known causes of postmenopausal bleeding.
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Bleeding |
| disease | MESH | Coronavirus Disease 2019 |
| disease | VO | vaccination |
| disease | VO | vaccine adverse event |
| disease | VO | dose |
| disease | VO | COVID-19 vaccine |
| disease | MESH | causes |
| disease | MESH | Adverse Drug Reaction |
| disease | MESH | Uterine Hemorrhage |